US SB5046 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on September 12 2024 - 25% progression
Action: 2024-09-12 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 12 2024 - 25% progression
Action: 2024-09-12 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.
Title
FDA Modernization Act 3.0
Sponsors
| Sen. Cory Booker [D-NJ] | Sen. Eric Schmitt [R-MO] | Sen. Rand Paul [R-KY] | Sen. Angus King [I-ME] |
| Sen. Mike Braun [R-IN] | Sen. Sheldon Whitehouse [D-RI] | Sen. John Kennedy [R-LA] | Sen. Ben Lujan [D-NM] |
| Sen. Richard Blumenthal [D-CT] | Sen. Roger Marshall [R-KS] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-09-12 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB7248 (Related) 2024-02-09 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/5046/all-info |
| Text | https://www.congress.gov/118/bills/s5046/BILLS-118s5046is.pdf |
